IMMU-03. THERAPEUTIC TARGETING OF TUMORIGENIC
EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA

Human glioblastoma (hGBM) carries a dismal prognosis and inevitably relapses despite aggressive therapy. Many of the 14 members of the Eph receptor tyrosine kinase family are expressed in hGBM initiating cells (GICs) and constitute potential molecular targets. We hypothesize that multiple members of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Qazi, Maleeha, Vora, Parvez, Venugopal, Chitra, Gorelik, Maryna, Singh, Mohini, Hu, Amy, Subapanditha, Minomi, Chokshi, Chirayu, Savage, Neil, Yelle, Nicholas, Adams, Jarrett, Moffat, Jason, Sidhu, Sachdev, Singh, Sheila
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692371/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.462
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы